Vivek Ramaswamy Quotes
I'd encourage more young people to apply their talents beyond finance and consulting and to think about reshaping how medicines are brought to market and how the business is run.
Vardi, Nathan. "Boy In The Bubble: How Vivek Ramaswamy Spun A 'Junk' Drug Into A $3 Billion Biotech." Forbes, 11 Apr. 2016.
The major killer diseases such as malaria and sleeping sickness are not contracted by Americans, and America is the only large country in the world where the Governments allow the drug companies to charge such high prices and make such huge profits. So any drug that Americans might pay for is a better potential profit generator than one that would be critical to the lives of millions where the governments to preserve lives would force the prices down or allow other companies to also make the drug. See {628648} for other factors affecting drug company priorities.
Vivek Ramaswamy is an American entrepreneur in the biotechnology sector. He is the founder and executive chairman of the biopharmaceutical company Roivant Sciences. Prior to founding Roivant in 2014, Ramaswamy co-founded a technology company and was a partner at an investment firm. He is a graduate of Harvard College and Yale Law School and has written about the undue influence of corporate power on American democracy.